Antiangiogenic drugs, crizotinib, and ICIs were associated with the development of hypogonadism in high-risk men who were treated for cancer. Hypogonadism and its management have an impact on symptom ...

Over a mean follow-up of 33 months, those who used topical 1.62% testosterone gel had a 0.19% incidence of high-grade prostate cancer (Gleason score ≥4 + 3), similar to the 0.12% among placebo-treated ...

Testosterone therapy was associated with lower risks for acute kidney injury and all-cause mortality among patients with hypogonadism and diabetes.

Hypogonadism is when the sex glands (gonads) produce little or no sex hormones. Low sex hormone levels (testosterone and estrogen) lead to low energy, decreased sex drive, and conditions like ...

Testosterone treatment in men with hypogonadism improves bone density and quality, but trials with a sufficiently large sample and a sufficiently long duration to determine the effect of testosterone ...

In a recent study published in Frontiers in Endocrinology, researchers evaluated whether insulin-like peptide 3 (INSL3) could predict hypogonadism and age-associated morbidity in older males. Study: ...

San Francisco — Tirzepatide is a promising treatment for metabolic hypogonadism in men with obesity, new research suggested. In a study of 83 men with obesity, functional hypogonadism, and insulin ...

Please provide your email address to receive an email when new articles are posted on . Men with metabolic hypogonadism had larger increases in testosterone levels with tirzepatide vs. testosterone ...